Immuneering Corporation (IMRX) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

Margin (%)

Operating Expenses

Research And Development ExpensesGeneral And Administrative ExpensesOther Expenses
02M5M8M10M12M15M18M20MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

EBITDA

EBITDA
-30M-26M-22M-19M-15M-11M-7M-4M1Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

EPS

Revenue Variation (%)

Income Variation (%)

Gross Profit VariationOperating Income Variation
062K125K188K250K312K375K438K500KQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Revenue YoY Variation (%)

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY Variation
050K100K150K200K250K300K350K400KQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Price-to-Earning Ratio

P/E Ratio
-20-17-15-12-10-7-4-21Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
0500M1B2B2B2B3B4B4BQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Per Share Metrics

Expense Ratios

💰 Cash Flow Statement

Operating Cash Flow

Free Cash Flow

Cash At End Of Period
038M75M112M150M188M225M262M300MQ4 2024Q1 2025Q2 2025Q3 2025

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
038M75M112M150M188M225M262M300MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025
🏦 Balance Sheet
📈 Key Metrics